Halberd (HALB) Stock Price, News & Analysis

Company Overview

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Key Stats

• Today's Range: $0.0018 to $0.0023
• 50-Day Range: N/A
• 52-Week Range: $0.0014 to $0.01
• Volume: 398,000 shs
• Average Volume: 822,572 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HALB Stock Analysis - Frequently Asked Questions

How have HALB shares performed this year?

Halberd's stock was trading at $0.0040 at the start of the year. Since then, HALB shares have decreased by 55.0% and is now trading at $0.0018.
View the best growth stocks for 2025 here.

How do I buy shares of Halberd?

Shares of HALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Halberd own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Halberd investors own include Vapor (HCMC), DatChat (DATS), BrewBilt Manufacturing (BBRW), Altamira Therapeutics (CYTO), Enzolytics (ENZC), Canoo (GOEV) and Jiuzi (JZXN).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:HALB
• CIK: 1458631
• Web: www.halberdcorporation.com
• Phone: (814) 786-8849
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A